American company DynaBio has received nearly 10 million US dollars of strategic investment from Zhongsheng Capital Global Innovation Fund and well-known Silicon Valley local venture capital institutions. This round of financing will be used for the company's upstream and downstream resource construction and technology research and development.
Reports show that DynaBio is a bio-nanotechnology company, focusing on the research and development and commercialization of nanomaterials and functions, bio-nanomaterials and nanomedical technology, and has established a series of dozens of categories of bio-micro-nanomaterial products, including Gold-like nanoparticles, silver nanoparticles, iron-based magnetic nanoparticles, nanoemulsions, nanomolecular carriers, intelligent magnetic response gels, quantum dots, etc., are widely used in cell magnetic labeling tracking, gene magnetic transfection, cell magnetic separation Selection, gene magnetic separation, magnetic / fluorescence immunochromatography detection, chemiluminescence detection, immunoprecipitation, magnetic resonance imaging, contrast, ultrasound imaging, photoacoustic imaging, dark field imaging, surface enhanced Raman detection, photothermal therapy and magnetic induction Hyperthermia and other fields.